US News

FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds

The agency could authorize Covid-19 boosters as soon as next week as concerns rise over a new, possibly more transmissible variant.

Jump To The Original Source

Facebook Comments

Check Also

Asia Stocks May Extend Drop on Fed Policy Concerns: Markets Wrap

Jump To The Original Source

Archives